Our focus is patients, 
Our passion is innovation®

MannKind Corporation develops patient-focused drug therapies and innovative technology solutions.

More

Advanced Science 
Practical Design

We specialize in innovative technologies with proven ease-of-use and patient acceptance.

More

Patient-Friendly
Inhalation Treatments

Needle-free, self-administered Inhalation Treatment Systems for both chronic and acute diseases.

More

In Partnership
Your Drug, Our Delivery.

Our Technosphere® technology can accommodate a wide variety of APIs required by specific drug therapies.

More

About Us

MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.  More

 

 

 

 

facebook-c_130x50      twitter_130x50

 

MannKind CEO, Michael Castagna, was recently interviewed on SiriusXM Business Radio Powered by The Wharton School. The show has shared the audio file of the 25-minute interview about Afrezza. Find it here

 

alfreeza

FDA Approved

For information about AFREZZA®,
please visit www.AFREZZA.com.

WARNING:


If you are reporting an Adverse Event and/or device complaint, please contact MannKind Medical Information at 1-877-323-8505 or MannKind@druginfo.com. Do not use this form for adverse events and/or device complaints.

Close